Stay updated on Combining MK-3475 and SBRT in Metastatic Melanoma or NSCLC Clinical Trial

Sign up to get notified when there's something new on the Combining MK-3475 and SBRT in Metastatic Melanoma or NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Combining MK-3475 and SBRT in Metastatic Melanoma or NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for a completed Yale study of pembrolizumab (MK-3475) combined with stereotactic radiotherapy in metastatic melanoma and NSCLC is now displayed. It includes the study plan, participant criteria, results, and a link to the study protocol.
    Difference
    53%
    Check dated 2026-11-10T14:42:48.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The site footer’s revision identifier was updated from v3.7.2 to v3.8.0 while the page continued to show a 403 error.
    Difference
    0.2%
    Check dated 2026-11-03T15:50:27.000Z thumbnail image
  3. Check
    27 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition from “Artificial Intelligence” to “Super Intelligence” terminology. The site revision changed from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T18:57:03.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T17:58:37.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with a minimal layout and a Home link, replacing the previous study content.
    Difference
    19%
    Check dated 2026-09-22T22:53:27.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.6 to v3.7.0, indicating a new version of the page. No study details or content appear to be changed.
    Difference
    0.1%
    Check dated 2026-09-15T21:38:14.000Z thumbnail image

Stay in the know with updates to Combining MK-3475 and SBRT in Metastatic Melanoma or NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Combining MK-3475 and SBRT in Metastatic Melanoma or NSCLC Clinical Trial page.